Status:
ACTIVE_NOT_RECRUITING
Efficacy of Respiratory Rehabilitation After COVID-19 Severe Infection
Lead Sponsor:
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Conditions:
COVID-19 Respiratory Infection
Rehabilitation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the effects of a training program in patients that have suffered a COVID infection
Detailed Description
Once patients have been selected and meet inclusion criteria, they will sign informed consent. They will make a first visit to obtain the basal parameters. Once done, they will start the individualize...
Eligibility Criteria
Inclusion
- Men and women ≥18 years
- Patients discharged from the Pulmonology Service with a diagnosis of COVID-19 by positive PCR and with severe pneumonia.
- At least three months after the presence of at least one of the following criteria:
- MRC dyspnea greater than or equal to 2.
- Decrease in the meters walked with respect to the reference values in the 6-minute walking test.
- C) Decreased respiratory muscle strength measured at Maximum Inspiratory Pressure (PIM) and / or Maximum Expiratory Pressure (PEM) with respect to reference values.
- Sign informed consent from the study
Exclusion
- Patients who do not want to be included in the study.
- Pregnant women.
- Impossibility to perform ergometry or ultrasound.
Key Trial Info
Start Date :
August 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05307562
Start Date
August 10 2021
End Date
December 1 2025
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Josep Trueta University Hospital
Girona, Spain, 17007